4.7 Article

Spontaneous and 5-fluorouracil-induced centrosome amplification lowers the threshold to resveratrol-evoked apoptosis in colon cancer cells

Journal

CANCER LETTERS
Volume 288, Issue 1, Pages 36-41

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2009.06.020

Keywords

Centrosome amplification; Apoptosis sensitivity; p53; 5-Fluorouracil; Resveratrol; Chemosensitization; Caspase-6

Categories

Funding

  1. [R364-000-053-213]
  2. [R364-000-061-112]

Ask authors/readers for more resources

We recently reported that caspase-6 activation is a major molecular event underlying resveratrol-triggered apoptosis in HCT116 colon cancer cells with or without p53. In the present study, we investigated the relationship between centrosome amplification and apoptosis sensitivity in cancer cells. We found that centrosome amplification, which occurs spontaneously in cancer cells, could be induced by a subtoxic concentration of 5-fluorouracil. Cancer cells with centrosome amplification, either spontaneous or 5-fluorouracil-induced, were more sensitive to apoptosis induction by resveratrol. In cancer cells, a subtoxic concentration of 5-fluorouracil also enhanced resveratrol-evoked caspase-6 activation. Functional loss of p53 promoted spontaneous, not 5-fluorouracil-induced, centrosome amplification. We conclude that centrosome amplification, either spontaneous or 5-fluorouracil-induced, confers higher apoptosis sensitivity to cancer cells. Drug induction of centrosome amplification might be a novel chemosensitization approach to cancer therapy. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Bizarre giant cells in human angiosarcoma exhibit chemoresistance and contribute to poor survival outcomes

Grace Fangmin Tan, Shane Goh, Abner Herbert Lim, Wei Liu, Jing Yi Lee, Vikneswari Rajasegaran, Xin Xiu Sam, Timothy Kwang Yong Tay, Sathiyamoorthy Selvarajan, Cedric Chuan-Young Ng, Bin Tean Teh, Jason Yongsheng Chan

Summary: Giant cells (GC) in angiosarcoma may contribute to tumor heterogeneity and treatment resistance, with higher GC content associated with poorer chemotherapy responses and worse overall prognosis in patients with angiosarcoma.

CANCER SCIENCE (2021)

Letter Medicine, General & Internal

Primary cutaneous umbilical melanoma

Ki Wei Tan, Jason Yongsheng Chan

ANNALS ACADEMY OF MEDICINE SINGAPORE (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

The exact Deauville score, NABS score and high SUVmax predicts outcome in extranodal natural killer/T-cell lymphoma

Hian Liang Huang, Pei Ing Ngam, Khee Ming Tan, David Chee Eng Ng, Soon Thye Lim, Jason Yongsheng Chan

Summary: This study aimed to investigate the prognostic utility of FDG-PET/CT and its role in complementing clinical indices in NKTCL patients. The results showed that a higher initial SUVmax was significantly associated with advanced disease stage, elevated LDH levels, and plasma EBV DNA detection. A Deauville score of 5 was found to be a more accurate indicator of disease progression, while the NABS score could be used for further risk stratification in patients with Deauville scores of 1-3.

ANNALS OF NUCLEAR MEDICINE (2021)

Correction Oncology

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma (vol 34, 3413, 2020)

Jing Quan Lim, Dachuan Huang, Tiffany Tang, Daryl Tan, Yurike Laurensia, Rou-Jun Peng, Esther Kam Yin Wong, Daryl Ming Zhe Cheah, Burton Kuan Hui Chia, Jabed Iqbal, Nicholas Francis Grigoropoulos, Maarja-Liisa Nairismagi, Cedric Chuan Young Ng, Vikneswari Rajasegaran, Huangming Hong, Seok Jin Kim, Junhun Cho, Eric Tse, Benjamin Mow, Qi-Chun Cai, Li-Mei Poon, Qing-qing Cai, Jing Tan, Jason Yongsheng Chan, Johnathan Xiande Lim, Yeow Tee Goh, Colin Phipps, Olaf Rotzschke, Chee Leong Cheng, Jeslin Chian Hung Ha, Lay Poh Khoo, Yvonne Su Ming Loh, Rex Au-Yeung, Thomas Sau-Yan Chan, Yok-Lam Kwong, William Hwang, Won Seog Kim, Jin-Xin Bei, Tongyu Lin, Choon Kiat Ong, Soon Thye Lim

LEUKEMIA (2021)

Article Pharmacology & Pharmacy

Clinical and economic evaluation of a surveillance protocol to manage hepatitis B virus (HBV) reactivation among lymphoma patients with resolved HBV infection receiving rituximab

Chia Jie Tan, Rajneesh Kumar, Narendran Koomanan, Wei Sheng Loo, Mohamad Farid, Miriam Tao, Nagavalli Somasundaram, Eileen Poon, Jason Yongsheng Chan, Valerie Shiwen Yang, Esther Chang, Soon Thye Lim, Wan Cheng Chow, Alexandre Chan, Tiffany Tang

Summary: The surveillance protocol for managing HBV reactivation among lymphoma patients receiving rituximab is effective, feasible, and cost-saving, with no reactivation-related events detected in the study.

PHARMACOTHERAPY (2021)

Article Oncology

Burkitt lymphoma - no impact of HIV status on outcomes with rituximab-based chemoimmunotherapy

Jing Yuan Tan, Tian Yu Qiu, Jianbang Chiang, Ya Hwee Tan, Valerie Shiwen Yang, Esther Wei Yin Chang, Eileen Poon, Nagavalli Somasundaram, Mohamad Farid, Miriam Tao, Soon Thye Lim, Jason Yongsheng Chan

Summary: We analyzed the prognostic factors for adult Burkitt lymphoma patients and found that the overall prognosis is good, with similar outcomes for patients with and without HIV. The presence of central nervous system disease, bone marrow involvement, and elevated LDH levels are associated with poorer prognosis.

LEUKEMIA & LYMPHOMA (2023)

Article Oncology

Rare Occurrence of Aristolochic Acid Mutational Signatures in Oro-Gastrointestinal Tract Cancers

Abner Herbert Lim, Jason Yongsheng Chan, Ming-Chin Yu, Tsung-Han Wu, Jing Han Hong, Cedric Chuan Young Ng, Zhen Jie Low, Wei Liu, Rajasegaran Vikneswari, Pin-Cheng Sung, Wen-Lang Fan, Bin Tean Teh, Sen-Yung Hsieh

Summary: This study investigates the prevalence and role of Aristolochic acid (AA) in tumorigenesis of oro-gastrointestinal tract cancers (OGITCs). The rarity of AA mutational signatures in OGITCs suggests that AA is unlikely to be a major driver of tumorigenesis in this specific type of cancer.

CANCERS (2022)

Article Genetics & Heredity

Multiregion sequencing of sarcomatoid renal cell carcinoma arising from autosomal dominant polycystic kidney disease

Elizabeth Lee, Peiyong Guan, Abner Herbert Lim, Jui Wan Loh, Grace Fangmin Tan, Tracy Loh, Dave Yong Xiang Ng, Jing Yi Lee, Shane Goh, Wei Liu, Cedric Chuan-Young Ng, Bin Tean Teh, Jason Yongsheng Chan

Summary: This study provides the initial molecular description of sarcomatoid renal cell carcinoma (sRCC) arising in the setting of Autosomal dominant polycystic kidney disease (ADPKD). Common pro-oncogenic signals are observed between ADPKD and sRCC, shedding light on their shared pathobiology.

MOLECULAR GENETICS & GENOMIC MEDICINE (2022)

Article Oncology

A Prognostic Model Using Post-Steroid Neutrophil-Lymphocyte Ratio Predicts Overall Survival in Primary Central Nervous System Lymphoma

Yu Tung Lo, Vivian Yujing Lim, Melissa Ng, Ya Hwee Tan, Jianbang Chiang, Esther Wei Yin Chang, Jason Yongsheng Chan, Eileen Yi Ling Poon, Nagavalli Somasundaram, Mohamad Farid Bin Harunal Rashid, Miriam Tao, Soon Thye Lim, Valerie Shiwen Yang

Summary: The study explores the prognostic value of hematological indices in primary central nervous system lymphomas (PCNSLs) and the impact of corticosteroids on these indices. It suggests that post-steroid NLR, when considered together with baseline NLR, can be a useful prognostic tool for accurate stratification of patients into different risk profiles related to survival outcomes.

CANCERS (2022)

Article Oncology

Therapeutic and immunomodulatory potential of pazopanib in malignant phyllodes tumor

Dave Yong Xiang Ng, Zhimei Li, Elizabeth Lee, Jessica Sook Ting Kok, Jing Yi Lee, Joanna Koh, Cedric Chuan-Young Ng, Abner Herbert Lim, Wei Liu, Sheng Rong Ng, Kah Suan Lim, Xi Xiao Huang, Jing Han Hong, Peiyong Guan, Yirong Sim, Aye Aye Thike, Nur Diyana Md Nasir, Shang Li, Puay Hoon Tan, Bin Tean Teh, Jason Yongsheng Chan

Summary: This study established a new model for malignant phyllodes tumors and provided evidence for the clinical efficacy of pazopanib in treating malignant phyllodes tumors.

NPJ BREAST CANCER (2022)

Review Biochemistry & Molecular Biology

The Multi-Dimensional Biomarker Landscape in Cancer Immunotherapy

Jing Yi Lee, Bavani Kannan, Boon Yee Lim, Zhimei Li, Abner Herbert Lim, Jui Wan Loh, Tun Kiat Ko, Cedric Chuan-Young Ng, Jason Yongsheng Chan

Summary: This review emphasizes the importance of investigating the tumor microenvironment and cellular heterogeneity in predicting immunotherapy outcomes. It summarizes the application and limitations of conventional technologies and biomarkers for this purpose, and discusses how emerging single-cell spatial omics can advance our understanding of interactions within the tumor microenvironment and aid in biomarker discovery for improving patient response prediction.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Cell Biology

Multi-omic profiling and real time ex vivo modelling of imatinib-resistant dermatofibrosarcoma protuberans with fibrosarcomatous transformation

Jason Yongsheng Chan, Elizabeth Chun Yong Lee, Zhimei Li, Jing Yi Lee, Abner Herbert Lim, Eileen Poon

Summary: We established a new patient-derived xenograft (PDX) and cell line model of imatinib-resistant DFSP with fibro-sarcomatous transformation. Whole genome sequencing and RNA sequencing identified gene alterations associated with DFSP and highlighted potential targetable signaling pathways. In cell experiments, certain antiangiogenic agents and a third-generation irreversible EGFR tyrosine kinase inhibitor exhibited modest anti-proliferative activity.

HUMAN CELL (2023)

Article Hematology

Post-Treatment Neutrophil and Lymphocyte Counts Predict Progression-Free Survival Following First-Line Chemotherapy in Hodgkin's Lymphoma

Grace Fangmin Tan, Siting Goh, Esther Wei Yin Chang, Ya Hwee Tan, Jianbang Chiang, Valerie Shiwen Yang, Eileen Yi Ling Poon, Nagavalli Somasundaram, Mohamad Farid Bin Harunal Rashid, Miriam Tao, Soon Thye Lim, Choon Kiat Ong, Jason Yongsheng Chan

Summary: Our study examines the prognostic value of immunologic changes in Hodgkin's lymphoma by investigating post-treatment lymphocyte count (pALC), neutrophil count (pANC), and the neutrophil-lymphocyte ratio (pNLR). We analyzed patients treated for classical Hodgkin's lymphoma and determined the optimal cutoff values for high pANC, low pALC, and high pNLR in predicting progression-free survival.

HEMATOLOGY REPORTS (2023)

Article Oncology

Classification of HER2-negative breast cancers by ERBB2 copy number alteration status reveals molecular differences associated with chromosome 17 gene aberrations

Jui Wan Loh, Abner Herbert Lim, Jason Yongsheng Chan, Yoon-Sim Yap

Summary: This study investigated the molecular features of non-metastatic HER2-negative breast cancers in relation to ERBB2 copy number alteration (CNA) status, revealing biological differences. Aberrations in other genes on chromosome 17 have important implications for ERBB2 non-neutral breast cancers.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2023)

Article Cell Biology

Ligand-mediated PAI-1 inhibition in a mouse model of peritoneal carcinomatosis

Josephine Hendrikson, Ying Liu, Wai Har Ng, Jing Yi Lee, Abner Herbert Lim, Jui Wan Loh, Cedric C. Y. Ng, Whee Sze Ong, Joey Wee-Shan Tan, Qiu Xuan Tan, Gillian Ng, Nicholas B. Shannon, Weng Khong Lim, Tony K. H. Lim, Clarinda Chua, Jolene Si Min Wong, Grace Hwei Ching Tan, Jimmy Bok Yan So, Khay Guan Yeoh, Bin Tean Teh, Claramae Shulyn Chia, Khee Chee Soo, Oi Lian Kon, Iain Beehuat Tan, Jason Yongsheng Chan, Melissa Ching Ching Teo, Chin-Ann J. Ong

Summary: This study demonstrates the importance of the STAT3 signaling pathway in peritoneal carcinomatosis and identifies potential activating ligands. The study also validates the prognostic biomarker panel, including PAI-1, and highlights a therapeutic opportunity based on paracrine addiction.

CELL REPORTS MEDICINE (2022)

Review Oncology

Small extracellular vesicles: Non-negligible vesicles in tumor progression, diagnosis, and therapy

Xinru Zhou, Yin Jia, Chuanbin Mao, Shanrong Liu

Summary: Small extracellular vesicles (sEVs), such as exosomes, have emerged as crucial targets for liquid biopsy and promising drug delivery vehicles in tumor progression. They can serve as biomarkers for tumor diagnosis and as drug carriers for cancer treatment.

CANCER LETTERS (2024)

Article Oncology

HMGB1 in the interplay between autophagy and apoptosis in cancer

Ruochan Chen, Ju Zhu, Xiao Zhong, Jie Li, Rui Kang, Daolin Tang

Summary: The interplay between autophagy and apoptosis plays a crucial role in tumorigenesis and cancer therapy, with HMGB1 serving as a key regulator in these processes.

CANCER LETTERS (2024)

Article Oncology

Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer

Zongfu Pan, Xixuan Lu, Tong Xu, Jinming Chen, Lisha Bao, Ying Li, Yingying Gong, Yulu Che, Xiaozhou Zou, Zhuo Tan, Ping Huang, Minghua Ge

Summary: This study uncovered the emerging role of HN1 in promoting dedifferentiation of anaplastic thyroid cancer (ATC) cells. HN1 negatively regulated the thyroid differentiation markers and had an inhibitory effect on the transcriptional activation of CTCF, thereby influencing the chromatin accessibility of thyroid differentiation genes.

CANCER LETTERS (2024)

Article Oncology

Autophagy machinery in glioblastoma: The prospect of cell death crosstalk and drug resistance with bioinformatics analysis

Yi Qin, Shengjun Xiong, Jun Ren, Gautam Sethi

Summary: Autophagy plays an important regulatory role in glioblastoma, and its dysregulation can lead to drug resistance and radioresistance. It also affects stem cell characteristics, overall growth, and metastasis. Therefore, autophagy is a promising target for glioblastoma therapy.

CANCER LETTERS (2024)

Article Oncology

Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase

Katsuya Nagaoka, Xuewei Bai, Dan Liu, Kevin Cao, Joud Mulla, Chengcheng Ji, Hongze Chen, Muhammad Azhar Nisar, Amalia Bay, William Mueller, Grace Hildebrand, Jin-Song Gao, Shaolei Lu, Hiroko Setoyama, Yasuhito Tanaka, Jack R. Wands, Chiung-Kuei Huang

Summary: This study found that serum 2-OG levels in cholangiocarcinoma patients are associated with the effectiveness of chemotherapy. Patients with progressive disease showed significantly higher levels of serum 2-OG compared to stable disease and partial response patients. The study also revealed that overexpression of ASPH mimics the effects of 2-OG, and knockdown of ASPH improves chemotherapy. Targeting ASPH enhances the effects of chemotherapy by modulating ATM and ATR, two key regulators of DDRs.

CANCER LETTERS (2024)